Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses
- 14 May 2020
- Vol. 70 (2), 319-329
- https://doi.org/10.1136/gutjnl-2019-319990
Abstract
Objectives To characterise the association between type 2 diabetes mellitus (T2DM) subtypes (new-onset T2DM (NODM) or long-standing T2DM (LSDM)) and pancreatic cancer (PC) risk, to explore the direction of causation through Mendelian randomisation (MR) analysis and to assess the mediation role of body mass index (BMI). Design Information about T2DM and related factors was collected from 2018 PC cases and 1540 controls from the PanGenEU (European Study into Digestive Illnesses and Genetics) study. A subset of PC cases and controls had glycated haemoglobin, C-peptide and genotype data. Multivariate logistic regression models were applied to derive ORs and 95% CIs. T2DM and PC-related single nucleotide polymorphism (SNP) were used as instrumental variables (IVs) in bidirectional MR analysis to test for two-way causal associations between PC, NODM and LSDM. Indirect and direct effects of the BMI-T2DM-PC association were further explored using mediation analysis. Results T2DM was associated with an increased PC risk when compared with non-T2DM (OR=2.50; 95% CI: 2.05 to 3.05), the risk being greater for NODM (OR=6.39; 95% CI: 4.18 to 9.78) and insulin users (OR=3.69; 95% CI: 2.80 to 4.86). The causal association between T2DM (57-SNP IV) and PC was not statistically significant (ORLSDM=1.08, 95% CI: 0.86 to 1.29, ORNODM=1.06, 95% CI: 0.95 to 1.17). In contrast, there was a causal association between PC (40-SNP IV) and NODM (OR=2.85; 95% CI: 2.04 to 3.98), although genetic pleiotropy was present (MR-Egger: p value=0.03). Potential mediating effects of BMI (125-SNPs as IV), particularly in terms of weight loss, were evidenced on the NODM-PC association (indirect effect for BMI in previous years=0.55). Conclusion Findings of this study do not support a causal effect of LSDM on PC, but suggest that PC causes NODM. The interplay between obesity, PC and T2DM is complex.Keywords
Funding Information
- Instituto de Salud Carlos III (PI0902102, PI11/01542, PI12/00815, PI12/01635, PI15/01573)
- Associazione Italiana Ricerca sul Cancro (12182)
- Cancer Focus Northern Ireland and Department for Employment and Learning
- Red Temática de Investigación Cooperativa en Cáncer (RD12/0036/0034, RD12/0036/0050, RD12/0036/0073)
- European Cooperation in Science and Technology (BM1204)
- Sixth Framework Programme (018771-MOLDIAG-PACA)
- ALF (SLL20130022)
- FP7 Health (256974-EPC-TM-Net, 259737-CANCERALIA)
This publication has 53 references indexed in Scilit:
- Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patientsNutrition, Metabolism and Cardiovascular Diseases, 2013
- Prevalence of Diabetes Mellitus in Pancreatic Cancer Compared to Common CancersPancreas, 2013
- Estimation of covariate effects in generalized linear mixed models with a misspecified distribution of random intercepts and slopesStatistics in Medicine, 2012
- Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset ageThe Esophagus, 2012
- Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studiesEuropean Journal of Cancer, 2011
- Weight Loss Precedes Cancer-Specific Symptoms in Pancreatic Cancer-Associated Diabetes MellitusPancreas, 2011
- Body Mass Index and Obesity- and Diabetes-Associated Genotypes and Risk for Pancreatic CancerCancer Epidemiology, Biomarkers & Prevention, 2011
- Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I dataCancer Causes & Control, 2011
- Mendelian Randomisation and Causal Inference in Observational EpidemiologyPLoS Medicine, 2008
- Flexible regression models with cubic splinesStatistics in Medicine, 1989